NasdaqGM - Delayed Quote USD
Prenetics Global Limited (PRE)
5.40
+0.08
+(1.50%)
At close: May 5 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 12M | 18M | 79.1M | 128.6M |
| Low Estimate | 12M | 18M | 79.1M | 128.6M |
| High Estimate | 12M | 18M | 79.1M | 128.6M |
| Year Ago Sales | 6.41M | 5.94M | 30.6M | 79.1M |
| Sales Growth (year/est) | 87.11% | 202.95% | 158.50% | 62.58% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.02 | -0.93 | -0.86 | -0.72 |
| EPS Actual | -0.7 | -0.88 | -0.84 | -1.29 |
| Difference | 0.32 | 0.05 | 0.02 | -0.57 |
| Surprise % | 31.37% | 5.38% | 2.33% | -79.17% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PRE | -- | -- | -- | -- |
| S&P 500 | 12.37% | 3.19% | 8.03% | 13.82% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/16/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 12/4/2024 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 4/4/2024 |
Related Tickers
WUXIF WuXi AppTec Co., Ltd.
7.34
0.00%
BNR Burning Rock Biotech Limited
2.4200
-13.26%
RSHN RushNet, Inc.
0.0002
0.00%
ADVB Advanced Biomed Inc. Common Stock
2.0700
+6.15%
RNVA Rennova Health, Inc.
0.0001
0.00%
GENE Genetic Technologies Limited
0.7650
0.00%
STRR Star Equity Holdings, Inc.
2.2600
+0.89%
SONA.CN Sona Nanotech Inc.
0.3000
+1.69%
BDSX Biodesix, Inc.
0.4743
-8.44%
OCX OncoCyte Corporation
2.9200
-4.26%